<?xml version='1.0' encoding='utf-8'?>
<document id="28316654"><sentence text="Predicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge." /><sentence text="Drug-drug interactions (DDIs) may lead to adverse effects and potentially result in drug withdrawal from the market" /><sentence text=" Predicting DDIs during drug development would help reduce development costs and time by rigorous evaluation of drug candidates" /><sentence text=" The primary mechanisms of DDIs are based on pharmacokinetics (PK) and pharmacodynamics (PD)" /><sentence text=" This study examines the effects of 2D structural similarities of drugs on DDI prediction through interaction networks including both PD and PK knowledge" /><sentence text=" Our assumption was that a query drug (Dq) and a drug to be examined (De) likely have DDI if the drugs in the interaction network of De are structurally similar to Dq" /><sentence text=" A network of De describes the associations between the drugs and the proteins relating to PK and PD for De" /><sentence text=" These include target proteins, proteins interacting with target proteins, enzymes, and transporters for De" /><sentence text=" We constructed logistic regression models for DDI prediction using only 2D structural similarities between each Dq and the drugs in the network of De" /><sentence text=" The results indicated that our models could effectively predict DDIs" /><sentence text=" It was found that integrating structural similarity scores of the drugs relating to both PK and PD of De was crucial for model performance" /><sentence text=" In particular, the combination of the target- and enzyme-related scores provided the largest increase of the predictive power" /><sentence text="Graphical abstract" /><sentence text="" /></document>